24-hour efficacy and safety of dorzolamide 2% versus brimonidine purite 0.15% each given twice daily when added to latanoprost 0.005% given each evening

Autor: Konstas A, Karabatsas CH, AL, Jackson, JA, Stewart, WC, Stewart

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1cfc17ebcaa6f30802bc301ab51d3407

A phase II trial of CI-921 in advanced malignancies

Autor: J. Leiby, A. Mittelman, Pj. Rosen, Francois Robert, Jacques Longueville, Lc. Panasci, Jacques Jolivet, Ja. Stewart, Am. Vandermerwe, Jc. Ruckdeschel, De. Bergsagel, Laura Benson, Nt. Sklarin, Ph. Wiernik, Wr. Grove, Jh. Doroshow, Nj. Robert, Cd. Kowal, Enrique Velez-Garcia, Ja. Maroun

Publikováno v: Investigational new drugs. 10(4)

CI-921, (9-[[2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino]- N,5-dimethyl-4-acridinecarboxamide 2-hydroxyethanesulfonate (1:1)), an anilinoacridine derivative with activity in experimental solid tumors was studied in a multicenter phase II trial in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f63d9224a8d379bd1c748e7e690393ee
https://pubmed.ncbi.nlm.nih.gov/1487405

Is there any difference in target intraocular pressure for exfoliative glaucoma patients with cardiovascular disease history?

Autor: Holló G, Cvenkel B, Ma, Teus, Mt, Irkec, Ys, Astakhov, Chiselita D, Petkova N, Liehneová I, Bartlomiej Kaluzny, Kóthy P, Bozkurt B, El, Akopov, Ja, Stewart, Ms, Kristoffersen, Cj, Kristoffersen, Wc, Stewart

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2068ea4c50bc168683afe47036eb92da
http://europepmc.org/abstract/med/20544681

PEY8 WHEN IS IT COST-EFFECTIVE TO TREAT OCULAR HYPERTENSION? RESULTS OF A DECISION-ANALYTIC HEALTH ECONOMIC MODEL

Autor: MA Mychaskiw, JA Stewart, WC Stewart, Q Nassar

Publikováno v: Value in Health. (6):A368

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db2f88f444fcba0154ab3364de6cb16

Conditional ablation of MCU exacerbated cardiac pathology in a genetic arrhythmic model of CPVT.

Autor: Deb A; Department of Biological Sciences, Mississippi State University, Starkville, MS 39762, USA., Tow BD; Department of Biological Sciences, Mississippi State University, Starkville, MS 39762, USA., Hao J; Plant Pathology Department, University of Florida, Gainesville, FL 32611, USA., Nguyen BL; Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL 32611, USA., Gomez V; Food Science and Human Nutrition Department, University of Florida, Gainesville, FL 32611, USA., Stewart JA Jr; School of Pharmacy, Department of BioMolecular Sciences, University of Mississippi, Oxford, MS 38677, USA., Smuder AJ; Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL 32611, USA., Knollmann BC; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA., Wang Y; Department of Biological Sciences, Mississippi State University, Starkville, MS 39762, USA.; Plant Pathology Department, University of Florida, Gainesville, FL 32611, USA., Liu B; Department of Biological Sciences, Mississippi State University, Starkville, MS 39762, USA.; Food Science and Human Nutrition Department, University of Florida, Gainesville, FL 32611, USA.

Publikováno v: Journal of molecular and cellular cardiology plus [J Mol Cell Cardiol Plus] 2024 Dec; Vol. 10. Date of Electronic Publication: 2024 Sep 10.